Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan
· Delayed Price · Currency is TWD 297.50
-0.50 (-0.17%)
At close: Dec 5, 2025
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 78.24 billion as of December 5, 2025. Its market cap has increased by 3.51% in one year.
Market Cap
78.24B
Enterprise Value
84.98B
Revenue
18.66B
Ranking
n/a
PE Ratio
16.49
Stock Price
297.50
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 78.24B, an increase of 751.56%. That is a compound annual growth rate of 20.82%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.95B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Lin BioScience | 34.87B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |
| Pegavision | 23.79B |